Case Report: Rapid response to gemtuzumab-ozogamicin in a pediatric patient with refractory systemic mastocytosis with AML1::ETO+ acute myeloid leukemia
This article describes a 6-year-old patient diagnosed with "systemic mastocytosis with AML1::ETO+ AML", he experience refractory disease during the course of treatment and salvage treatment was ineffective. The patient was administered gemtuzumab-ozogamicin therapy, resulting in rapid remission.
Authors
- Song Xue (ORCID: https://orcid.org/0000-0003-0459-2229)
- Lina Zhang (ORCID: https://orcid.org/0000-0002-7742-0252)
- Tong Wang (ORCID: https://orcid.org/0000-0002-9803-2291)
- Man Chen (ORCID: https://orcid.org/0009-0006-4599-7328)
- Xingyu Cao
- Hui-Peng Sun
Institutions
- Beijing Dao Pei Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1566805
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.00